It certainly wasn’t the deal Amgen investors were expecting from their new executive team: This morning, the Thousand Oaks, Calif., biotechnology giant dropped $415 million on DeCode Genetics, a ...
"“There is enough content in the world. What is missing is clarity — the kind of understanding that helps people make sense of life, decisions, identity, change, and purpose. Decode is my way of ...